← Leaderboards
David Murray
University Of Texas Hlth Sci Ctr San Ant
$759,954
Attributed
$759,954
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$759,954 · 4
By mechanism
M01$759,954 · 4
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Oscar R Benavente$24,209,089
- Kelly J Hunt$9,165,512
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHeart Disorder ChemotherapyHuman Therapy EvaluationDrug Screening /EvaluationCongestive Heart FailureLongitudinal Human StudyBeta Antiadrenergic AgentMedical Implant ScienceImplantable DefibrillatorsHuman MortalityOutcomes ResearchSudden Cardiac DeathAmiodaroneCombination TherapyCardiovascular Disorder PreventionRacial /Ethnic DifferenceClinical Trial Phase IHospital Patient CareMedical ComplicationImplantGender DifferenceWarfarinClinical Trials
Grant awards (10)
Prevention of Sudden Cardiac Death in Heart Failure$20,240
M01 · FY2004 · RR
Warfarin &Antiplatelet Therapy in Chronic Heart Failure$18,794
M01 · FY2004 · RR
BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)$234,837
M01 · FY2002 · RR
BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)$234,837
M01 · FY2002 · RR
PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE$0
M01 · FY2002 · RR
PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE$0
M01 · FY2002 · RR
BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)$234,837
M01 · FY2001 · RR
PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE$0
M01 · FY2001 · RR
BETA-BLOCKER EVALUATION OF SURVIVAL TRIAL (BEST)$16,409
M01 · FY2000 · RR
PREVENTION OF SUDDEN CARDIAC DEATH IN HEART FAILURE$0
M01 · FY2000 · RR